Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...
Researchers conducted a pragmatic, randomized, placebo-controlled, phase 3 trial, in collaboration with 64 general practices in Amsterdam, to evaluate the effectiveness of low doses of the ...